Periscope Capital’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-178,393
Closed -$1.79M 970
2022
Q3
$1.79M Buy
178,393
+1,400
+0.8% +$14K 0.05% 512
2022
Q2
$1.75M Buy
176,993
+78,600
+80% +$778K 0.05% 556
2022
Q1
$970K Buy
98,393
+19,895
+25% +$196K 0.03% 623
2021
Q4
$766K Hold
78,498
0.02% 606
2021
Q3
$768K Buy
+78,498
New +$768K 0.02% 573